Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3663729
Max Phase: Preclinical
Molecular Formula: C19H17F3N6O2
Molecular Weight: 418.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3663729
Max Phase: Preclinical
Molecular Formula: C19H17F3N6O2
Molecular Weight: 418.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccc([C@H]2CNCCO2)cc1)c1ccn(-c2cc(C(F)(F)F)ncn2)n1
Standard InChI: InChI=1S/C19H17F3N6O2/c20-19(21,22)16-9-17(25-11-24-16)28-7-5-14(27-28)18(29)26-13-3-1-12(2-4-13)15-10-23-6-8-30-15/h1-5,7,9,11,15,23H,6,8,10H2,(H,26,29)/t15-/m1/s1
Standard InChI Key: BISNTGVXBFUUJV-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 418.38 | Molecular Weight (Monoisotopic): 418.1365 | AlogP: 2.59 | #Rotatable Bonds: 4 |
Polar Surface Area: 93.96 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.11 | CX LogP: 2.87 | CX LogD: 2.09 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.68 | Np Likeness Score: -1.70 |
1. (2015) Pyrazole derivatives, |
Source(1):